Western blotting revealed that the activities of CHIP alone and together with GA (HSP90 inhibitor) correlated with the suppression of hyperglycemia-induced p53, while CHIP depletion was unable to produce the desired effect (Fig. 5A). Here, TP53 is linked to Hyperglycemia.